A Likely Breakthrough For Prostate Cancer Patients

by Medindia Content Team on  March 15, 2004 at 1:37 PM Research News
RSS Email Print This Page Comment bookmark
Font : A-A+

A Likely Breakthrough For Prostate Cancer Patients
Most men with prostate cancer would rather find out sooner than later if they have the disease. At present, men are tested for prostate cancer using the prostate-specific antigen test. But since PSA levels normally go up and down over time, it's hard for doctors to know what a high reading is and what may just be normal for any particular man. Hence men with higher levels have to undergo repeated biopsies to determine whether they have cancer or not.

Researchers from the University of Pittsburgh hopes to make the PSA test a thing of the past with a new test called EPCA. The protein shows up at the very earliest stages of cancer. The test has already shown success in a laboratory study, and now
researchers are getting ready to see how it works in patients. Researchers say ,by testing for EPCA in men with high levels of PSA, they feel that they may be able to detect the presence of prostate cancer earlier, before it is discoverable by biopsy, thus saving patients the fear and stress of repeat procedures and enabling us to treat the disease sooner.

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Prostate Cancer Cancer and Homeopathy Trans-Urethral Resection of the Prostate Prostate Cancer Facts Cancer Facts Cancer Prostate Cancer: Treatment Options Prostate Specific Antigen [PSA] Nutrition All Men Need Common Lifestyle Habits that Cause Diseases 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive

Loading...